Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
4-hydroxy-3-methoxyphenyl-β-ketopropionyl-CoA thiolase is a bacterial enzyme involved in the catabolism of hydroxycinnamic acids, such as ferulic acid [1, 2]. It catalyzes the thiolytic cleavage of 4-hydroxy-3-methoxyphenyl-β-ketopropionyl-CoA (HMPKP-CoA) into vanilloyl-CoA and acetyl-CoA, a reaction analogous to the final step of fatty acid beta-oxidation [4, 5]. This enzyme is particularly well-characterized in the soil bacterium Agrobacterium fabrum, where it is encoded by the gene atu1421 and is essential for the microbial degradation of plant-derived aromatic compounds [2, 3]. While the enzyme is of significant interest in environmental microbiology and for the biotechnological production of vanillin from lignin, it does not have a human ortholog or a known role in human physiology [2, 4]. Consequently, there are currently no therapeutic drugs that target this enzyme, and it is not considered a target for clinical drug development.
No known therapeutic drugs target this enzyme.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 4-hydroxy-3-methoxyphenyl-β-ketopropionyl-CoA thiolase (HMPKP-CoA thiolase).